BioSpace News Archive

ConnectiveRx announced it was named Trailblazer 2020 Company of the Year in the supplier/vendor category by PM360, a leading trade magazine for the pharmaceutical, biotech, medical device and diagnostics industries.

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today announced initial data from its ongoing Phase 1 study of tidutamab (XmAb ® 18087), an SSTR2 x CD3 bispecific antibody, in patients with neuroendocrine tumors (NETs). The data were presented at the North American Neuroendocrine Tumor Society’s 2020 Mu

ENDRA Life Sciences Inc. (“ENDRA”) (NASDAQ:NDRA), the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that management will present at the 4th Annual H.C. Wainwright NASH Investor Conference.

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , announced today that it has received notification from the U.S. Food and Drug Administration (FDA) that the company’s submitted Investigational New Drug application (IND) has been placed on hold. The notification gave

Matrix Medical Network® (Matrix) today announced the acquisition of Biocerna, a CLIA-certified and CAP-accredited laboratory dedicated to delivering clinical diagnostics tests to improve patients’ safety and quality of care.

Researchers at RTI International — Dr. Pia MacDonald and Dr. Meera Viswanathan — have been tracking the COVID pandemic since its start using real data and on-the-ground experience from past infectious disease outbreaks to conduct research that provides insights and recommendations for best practices for effective COVID testing,

Lateral flow assay is used to confirm the presence or absence of a target analyte such as pathogens or biomarkers in humans or animals.

Cardiovascular diseases comprise disorders and conditions related to circulatory system which include heart and vascular system.

bluebird bio, Inc. announced that the European Medicines Agency accepted the company’s marketing authorization application for its investigational elivaldogene autotemcel gene therapy for the treatment of patients with cerebral adrenoleukodystrophy.

New Heat Extraction Scientific Testing Method and Technology Improves COVID-19 Molecular Test Efficiency and Throughput